BELATACEPT (Nulojix®)
Clinical Indication
Immunosuppressive therapy for Kidney Transplant in Adults and Children/Young People
Comments
In line with NICE TA 481, NICE TA 482
Date of classification
January 2018
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.